Autisme
Published on September 11, 2026
Risk Factors
Male sex (4:1 male-to-female ratio), family history of autism spectrum conditions, advanced parental age, certain genetic syndromes (Fragile X, Tuberous Sclerosis), prenatal exposure to valproate, very low birth weight or extreme prematurity
Etiology
Neurodevelopmental; multifactorial involving genetic susceptibility and environmental influences affecting brain connectivity and synaptic development. Not caused by parenting style or vaccines.
Presentation
Parent brings a child (typically under 3 years old) with concerns about delayed speech, not responding to their name, lack of eye contact, preferring to play alone, and repetitive behaviors
Classic Exam
Absence of joint attention (not pointing or following gaze), lack of social smile or socio-emotional reciprocity, poor eye contact, stereotyped motor movements (hand flapping, spinning, rocking), rigid adherence to routines, unusual attachments to non-soft objects
Diagnostics
Clinical diagnosis based on behavioral observation and developmental history. Screening tools: M-CHAT-R/F (toddlers). Formal assessment: ADOS-2 and ADI-R. No single lab or imaging test confirms the diagnosis.
Management
Applied Behavior Analysis (ABA) as the cornerstone early intervention, speech-language therapy, occupational therapy, social skills training. Pharmacotherapy is adjunctive and symptom-targeted only (e.g., risperidone for irritability/aggression).
01Pathophysiology
Childhood autism is a pervasive developmental disorder rooted in atypical neurodevelopment that begins during prenatal brain formation and manifests behaviorally in early childhood. The PPDGJ-III emphasizes that abnormalities must be present before the age of 3 years, reflecting the early-onset nature of this condition.
The underlying mechanism involves disrupted neural connectivity. During normal brain development, neurons form organized networks that support social cognition, language processing, and behavioral flexibility. In autism, there is evidence of both local over-connectivity (excessive short-range synaptic connections within brain regions) and long-range under-connectivity (deficient communication between distant brain areas such as the prefrontal cortex and posterior temporal regions). This imbalance helps explain why children with autism may excel in detail-oriented tasks but struggle with integrating complex social information.
The mirror neuron system, which underpins the ability to imitate others and understand their intentions, shows functional differences in autism. This directly explains the PPDGJ-III criterion of impaired social imitative play and the difficulty in reading non-verbal cues. When vignettes describe a child who "does not imitate waving bye-bye" or "does not engage in pretend play," they are testing your understanding of this mechanism.
The amygdala and its connections to the fusiform face area are also implicated. Early amygdala overgrowth followed by arrested development contributes to impaired face processing and emotional recognition, which maps directly to the PPDGJ-III description of "inadequate appreciation of socio-emotional cues" and "lack of emotional response to others' verbal and non-verbal expressions."
Repetitive and stereotyped behaviors are linked to basal ganglia and corticostriatal circuit dysfunction, resulting in an overreliance on habitual motor programs and difficulty shifting between behavioral sets. This explains the "insistence on sameness" and distress when routines are disrupted.
Genetic factors play a substantial role, with heritability estimates exceeding 80%. However, no single gene is responsible. Hundreds of genes are implicated, many converging on pathways involved in synaptic formation, chromatin remodeling, and transcriptional regulation (e.g., SHANK3, CHD8, MECP2). Environmental modifiers such as prenatal valproate exposure and advanced paternal age act on these vulnerable genetic backgrounds.
Importantly, approximately three-quarters of children with childhood autism also have intellectual disability (mental retardation), as noted explicitly in the PPDGJ-III. However, all IQ levels can be found, and the presence of normal or high IQ does not exclude the diagnosis.
02Classification and Clinical Manifestation
The PPDGJ-III organizes the clinical features of childhood autism into three core domains, often referred to as the "triad of impairments."
Triad of Impairments
Domain | Clinical Features |
|---|---|
Impaired Social Interaction | Poor eye contact; failure to develop peer relationships; absence of social or emotional reciprocity; lack of spontaneous sharing of enjoyment or interests (e.g., not showing toys to parents); inability to modulate behavior according to social context; weak integration of social, emotional, and communicative behaviors |
Impaired Communication | Delay or total absence of spoken language without compensatory gesture; inability to initiate or sustain conversation; stereotyped and repetitive use of language (echolalia); lack of varied, spontaneous make-believe or social imitative play; poor flexibility in expressive language; absence of prosodic variation (monotone speech); lack of accompanying gestures |
Restricted, Repetitive Behavior, Interests, and Activities | Preoccupation with one or more stereotyped patterns of interest (abnormal in intensity or focus, e.g., dates, routes, schedules); inflexible adherence to nonfunctional routines or rituals; stereotyped motor mannerisms (hand flapping, finger twisting, whole-body rocking); persistent preoccupation with parts of objects or non-functional aspects (smell, texture); marked distress over small environmental changes (furniture rearrangement, room decoration changes); unusual attachment to odd, non-soft objects |
Severity and Associated Features
Feature | Detail |
|---|---|
Intellectual Function | About 75% have comorbid intellectual disability; all IQ levels are possible |
Onset | Symptoms present before 3 years; usually no clearly normal early developmental period |
Age at Diagnosis | Can be diagnosed at any age, but behavioral features are most apparent in early childhood |
Sex Ratio | Approximately 4:1 male to female |
Associated Conditions | Epilepsy (up to 25-30%), sleep disturbances, feeding difficulties, self-injurious behavior, sensory hypersensitivity or hyposensitivity |
03Diagnostic Workup
Test | Role | Key Findings |
|---|---|---|
M-CHAT-R/F | Best initial screening tool (16-30 months) | Flags risk based on parent-reported social-communication behaviors |
ADOS-2 (Autism Diagnostic Observation Schedule) | Most accurate standardized observational assessment | Semi-structured interaction assessing social communication and repetitive behaviors across modules matched to language level |
ADI-R (Autism Diagnostic Interview-Revised) | Confirmatory caregiver interview | Detailed developmental history covering the triad of impairments |
Developmental/IQ Testing | Determines intellectual function and adaptive level | Establishes presence/severity of intellectual disability (relevant given 75% comorbidity) |
Hearing Assessment (Audiometry/ABR) | Rule out hearing loss as cause of language delay | Normal hearing in autism; abnormal in hearing-related speech delay |
Genetic Testing (Chromosomal microarray, Fragile X) | Etiologic workup, not diagnostic of autism itself | Identifies syndromic causes (Fragile X, chromosomal deletions/duplications) |
EEG | Only if seizures suspected | Not routine; indicated when there is clinical concern for epilepsy |
Neuroimaging (MRI) | Not routinely indicated | Only if focal neurological signs, macrocephaly with regression, or suspected structural abnormality |
The diagnosis of childhood autism under the PPDGJ-III is fundamentally clinical. There is no laboratory test, biomarker, or imaging study that confirms the diagnosis. The diagnostic process relies on a combination of detailed developmental history, direct behavioral observation, and exclusion of other conditions.
The best initial step when a parent raises concern about a toddler's social or communicative development is to administer the M-CHAT-R/F (Modified Checklist for Autism in Toddlers, Revised with Follow-Up). This is a parent-completed screening questionnaire designed for children between 16 and 30 months. It is not diagnostic but stratifies risk and identifies children who need formal evaluation.
The most accurate test for confirming the diagnosis is a comprehensive evaluation that includes the ADOS-2 (a clinician-administered, semi-structured observational assessment) and the ADI-R (a structured caregiver interview). The ADOS-2 is considered the gold standard observational instrument. It uses standardized "presses" for social interaction, communication, play, and repetitive behaviors to generate a diagnostic algorithm score.
A critical part of the workup is audiometry or auditory brainstem response (ABR) testing to rule out hearing impairment as a cause of language delay. This step is frequently tested: if a child presents with language delay, you must exclude hearing loss before attributing symptoms to autism.
Developmental and IQ testing should be performed in all cases, given the high rate of comorbid intellectual disability emphasized in the PPDGJ-III (approximately 75%). The result also guides educational and intervention planning.
Genetic testing (chromosomal microarray and Fragile X DNA testing) is recommended as part of the etiologic workup but does not confirm or exclude autism. Routine neuroimaging and EEG are not indicated unless there are additional clinical concerns (seizures, regression, focal neurological findings, or significant macrocephaly).
04Management and Treatment
Intervention | Indication | Details |
|---|---|---|
Applied Behavior Analysis (ABA) | Core intervention for all children with autism | Intensive (25-40 hours/week ideal for young children); evidence-based; targets social, communication, and adaptive skills |
Speech-Language Therapy | Communication impairment | Targets functional language, pragmatics, augmentative/alternative communication (AAC) if nonverbal |
Occupational Therapy | Sensory processing difficulties, fine motor deficits, daily living skills | Sensory integration approaches, self-care skill training |
Social Skills Training | Social interaction deficits | Structured group-based programs, peer-mediated interventions |
Risperidone | Irritability, aggression, self-injury in autism (age 5+) | 0.25-0.5 mg/day initial, titrate to 0.5-3 mg/day; FDA-approved for irritability in autism; monitor for weight gain, metabolic syndrome, hyperprolactinemia |
Aripiprazole | Irritability in autism (age 6+) | 2 mg/day initial, titrate to 5-15 mg/day; FDA-approved; lower metabolic risk than risperidone but akathisia is common |
Melatonin | Sleep-onset insomnia | 0.5-5 mg at bedtime, 30-60 minutes before desired sleep time; first-line pharmacotherapy for sleep difficulties |
SSRIs (e.g., Fluoxetine) | Comorbid anxiety, OCD-like repetitive behaviors (adolescents/adults) | Used off-label; start low, go slow; limited evidence in young children |
The cornerstone of autism management is early, intensive behavioral intervention, not pharmacotherapy. The single most testable principle is that Applied Behavior Analysis (ABA) is the best-studied and most strongly recommended intervention, particularly when initiated before age 4 and delivered at high intensity (25-40 hours per week). ABA uses structured, repetitive learning trials with reinforcement to build social, communicative, and adaptive behaviors while reducing harmful or disruptive ones.
Speech-language therapy is essential for nearly all children with autism, addressing not just expressive and receptive language but also pragmatic communication (turn-taking, topic maintenance, understanding indirect language). For nonverbal children, the introduction of augmentative and alternative communication (AAC) systems, such as picture exchange systems (PECS) or speech-generating devices, is a priority. A common exam trap is assuming that AAC discourages spoken language development; it does not, and in fact often facilitates it.
Occupational therapy addresses sensory processing challenges, fine motor skills, and activities of daily living. Many children with autism have either hypersensitivity (covering ears in noisy environments) or hyposensitivity (seeking deep pressure) to sensory input.
Pharmacotherapy is strictly adjunctive and symptom-targeted. No medication treats the core features of autism (social impairment, communication deficits). The two FDA-approved medications for irritability/aggression/self-injury associated with autism are:
Risperidone (approved for age 5 and above): Initial dose 0.25 mg/day for children under 20 kg, 0.5 mg/day for those 20 kg or above. Titrate gradually over 2 weeks to an effective dose (typically 0.5-3 mg/day). Monitor weight, fasting glucose, lipid panel, and prolactin levels.
Aripiprazole (approved for age 6 and above): Initial dose 2 mg/day, titrated to 5-15 mg/day. Lower risk of weight gain and metabolic effects compared to risperidone, but akathisia (restlessness) is a notable side effect.
Melatonin is first-line for the very common comorbidity of sleep-onset insomnia, dosed at 0.5-5 mg given 30-60 minutes before the desired bedtime.
There is no role for chelation therapy, secretin, hyperbaric oxygen, or restrictive diets (e.g., gluten-free/casein-free) as evidence-based treatments. Questions that offer these as answer choices are testing your ability to identify unproven interventions.
05Differential Diagnosis and Distractors
Differential | Why It Looks Similar | Key Discriminator |
|---|---|---|
Rett Syndrome | Developmental regression, stereotyped hand movements, social withdrawal | Almost exclusively in females; normal development until 6-18 months followed by loss of purposeful hand use replaced by hand-wringing/hand-washing stereotypies; progressive microcephaly; identified by MECP2 gene mutation |
Childhood Disintegrative Disorder (Heller Syndrome) | Regression in social and communication skills, onset of stereotyped behaviors | At least 2 years of clearly normal development before dramatic regression across multiple domains (language, social, bowel/bladder, play, motor skills); much rarer than autism |
Asperger Syndrome (per PPDGJ-III) | Impaired social interaction, restricted interests, stereotyped behaviors | No clinically significant delay in language or cognitive development; normal IQ; speech develops on time but pragmatic use is impaired; lack of "language delay" in the vignette is the key discriminator |
Intellectual Disability (without autism) | Delayed milestones, limited communication | Social interest and reciprocity are preserved relative to mental age; the child attempts to engage socially even if skills are limited; no stereotyped/repetitive behavior pattern beyond what is expected for cognitive level |
Specific Language Disorder (SLI) | Delayed speech and language development | Social interaction, imaginative play, and nonverbal communication are intact; the child compensates with gestures and eye contact; no repetitive/stereotyped behaviors |
Hearing Impairment | Appears unresponsive to name, delayed speech | Responds to visual cues and uses gestures; audiometry/ABR is abnormal; social reciprocity through visual channels is preserved |
Reactive Attachment Disorder | Social withdrawal, poor eye contact, lack of emotional reciprocity | History of severe neglect, institutional care, or frequent caregiver changes; symptoms improve markedly when placed in a nurturing environment; no stereotyped behaviors or restricted interests |
Selective Mutism | Appears uncommunicative, may seem socially withdrawn | Speaks normally in comfortable settings (e.g., at home) but not in others (e.g., school); social interaction and play are normal outside the anxiety-provoking context; no repetitive behaviors |
06Traps and High-Yield Pearls
The most common way students lose points on autism questions is by confusing language delay with autism or by selecting a diagnostic test when the answer is clinical observation. A vignette describing a 2-year-old who does not speak yet but points, makes eye contact, and plays peek-a-boo is not autism. The child has preserved social reciprocity and nonverbal communication, pointing instead toward isolated language delay or hearing impairment. Always look for the social dimension: the absence of joint attention, social smile, and emotional reciprocity is what separates autism from other causes of language delay.
A second common trap involves the age criterion. The PPDGJ-III states that symptoms must appear before age 3. If a vignette describes a child who developed completely normally until age 4 and then lost skills, think Childhood Disintegrative Disorder, not childhood autism. Similarly, if there is normal early language and cognitive development with isolated social oddity, think Asperger Syndrome.
Students also frequently err by selecting MRI or EEG as the diagnostic test. These are not routine and are not confirmatory for autism. The diagnosis is clinical. Audiometry, however, should always be performed to exclude hearing loss, and this is a commonly tested "next best step" when a child presents with language delay.
On the treatment side, the trap is selecting a medication as first-line therapy. No medication treats the core symptoms of autism. The best initial intervention is always behavioral (ABA), and pharmacotherapy is reserved for comorbid symptoms like irritability, aggression, or insomnia. If a vignette describes a child with autism who is aggressive and self-injurious despite behavioral interventions, the next step is risperidone or aripiprazole, not an SSRI or stimulant.
Finally, remember the IQ pearl from the PPDGJ-III: approximately 75% of children with childhood autism have comorbid intellectual disability, but all IQ levels can occur. A vignette of a child with autism and a normal IQ does not rule out the diagnosis, and this is a frequent distractor designed to make you second-guess yourself.